Eighty cirrhotic patients who had recovered from an episode of spontaneous bacterial peritonitis were included in a multicenter, double-blind trial aimed at comparing long-term norfloxacin administration (400 mglday; 40 patients) vs. placebo (40 patients) in the prevention of spontaneous bacterial p
Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: Results of a prospective controlled trial
✍ Scribed by Alain Rolachon; Laurent Cordier; Yannick Bacq; Jean-Baptiste Nousbaum; Anne Franza; Jean-Claude Paris; Serge Fratte; Benoit Bohn; Pascal Kitmacher; Jean-Paul Stahl; Jean-Pierre Zarski
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 525 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objectives/Hypothesis: To investigate 1) whether the Provox ActiValve results in increased device‐life in individuals with below average device‐life, 2) whether it is cost‐effective, and 3) whether it has any impact on voice‐related quality of life. ## Study Design: Prospective st
Cefotaxime (CTX) is considered one of the first-choice antibiotics in the therapy of spontaneous bacterial peritonitis (SBP) in cirrhosis. Because CTX is largely metabolized in the liver, this drug may also be effective in SBP by administering lower doses than those habitually used. To investigate t
## Background: For patients treated with combination resection and postoperative radiotherapy, the interval between surgery and completion of radiotherapy represents an opportunity for tumor repopulation and treatment failure. a prospective trial to test the feasibility and efficacy of accelerated
## Background: Postoperative recurrence (PR) occurs early after intestinal resection in Ͼ75% of Crohn's disease (CD) patients. No well-established strategy for long-term PR prevention is available. The aim was to prospectively evaluate the long-term endoscopic and clinical outcomes of postoperative